The P2X7 receptor gene polymorphism 1513 A→C has no effect on clinical prognostic markers, in vitro sensitivity to fludarabine, Bcl‐2 family protein expression or survival in B‐cell chronic lymphocytic leukaemia (Q44597139)
Jump to navigation
Jump to search
scientific article published on October 1, 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The P2X7 receptor gene polymorphism 1513 A→C has no effect on clinical prognostic markers, in vitro sensitivity to fludarabine, Bcl‐2 family protein expression or survival in B‐cell chronic lymphocytic leukaemia |
scientific article published on October 1, 2003 |
Statements
1 reference
The P2X7 receptor gene polymorphism 1513 A-->C has no effect on clinical prognostic markers, in vitro sensitivity to fludarabine, Bcl-2 family protein expression or survival in B-cell chronic lymphocytic leukaemia (English)
1 reference
The P2X7 receptor gene polymorphism 1513 A→C has no effect on clinical prognostic markers, in vitro sensitivity to fludarabine, Bcl‐2 family protein expression or survival in B‐cell chronic lymphocytic leukaemia (English)
Jane Starczynski
1 reference
Guy Pratt
1 reference
Laura Hooper
1 reference
Alun Thomas
1 reference
Terry Hoy
1 reference
Donald Milligan
1 reference
Paul Bentley
1 reference
Christopher Fegan
1 reference
1 October 2003
1 reference
1 reference
123
1 reference
1
1 reference
66-71
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference